First Pacific Advisors, LP Abbott Laboratories Transaction History

First Pacific Advisors, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $97,816 - $114,754	-1,029 Reduced 26.87%	2,800 $307,000
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $92,566 - $108,963	-875 Reduced 18.6%	3,829 $444,000
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $15,330 - $16,705	-146 Reduced 3.01%	4,704 $515,000
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $6,622 - $8,006	-100 Reduced 2.02%	4,850 $388,000
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $593,318 - $672,143	-9,050 Reduced 64.64%	4,950 $358,000
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $391,476 - $432,072	-6,800 Reduced 32.69%	14,000 $854,000
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $737,137 - $833,422	13,100 Added 170.13%	20,800 $1.25 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $413,336 - $442,519	7,700	7,700 $439,000

3,376

1.36B

10.6M

8.72M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $221B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of First Pacific Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on First Pacific Advisors, LP with notifications on news.